NCT06794762 Effects of Core Stabilization Exercises in Children with Acute Lymphoblastic Leukemia
| NCT ID | NCT06794762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karamanoğlu Mehmetbey University |
| Condition | Acute Lymphoblastic Leukemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-01-14 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-01-14 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of core stabilization exercises applied in addition to the conventional exercise program on physical function, functional muscle strength, functional exercise capacity, postural control and fatigue in children with acute lymphoblastic leukemia receiving maintenance treatment. Participants will be divided into two groups; the first group will be given a conventional exercise program, while the second group will be given core stabilization exercises in addition to the conventional exercise program.
Eligibility Criteria
Inclusion Criteria: * Children aged 7-18 * Diagnosed with ALL * In the maintenance phase of chemotherapy * Children without acute thrombosis, active ischemia, hemodynamic instability * Children without uncontrolled pain * Children who can follow verbal instructions. Exclusion Criteria: * Children who have received or are receiving cranial radiotherapy * Children with any cardiovascular disease, acute or chronic respiratory disease * Children with acute or chronic bone, joint, muscle problems * Children diagnosed with neuromotor deficits or genetic disorders * Children with vision problems other than refractive errors
Frequently Asked Questions
Who can join the NCT06794762 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Acute Lymphoblastic Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06794762 currently recruiting?
Yes, NCT06794762 is actively recruiting participants. Visit ClinicalTrials.gov or contact Karamanoğlu Mehmetbey University to inquire about joining.
Where is the NCT06794762 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT06794762 clinical trial?
NCT06794762 is sponsored by Karamanoğlu Mehmetbey University. The trial plans to enroll 34 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.